Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria

Launched by MEMORIAL SLOAN KETTERING CANCER CENTER · Aug 3, 2020

Keywords

ClinConnect Summary

This clinical trial is focused on improving breast cancer diagnosis in Nigeria by training local radiologists to perform ultrasound-guided breast biopsies. The goal is to ensure that women who come to the hospital with a suspicious breast mass can receive safe and effective biopsies. Before they start working with patients, these radiologists will complete a special training program that has been developed by experts from Nigeria and the United States. This program helps them gain the necessary skills to perform the procedure confidently.

To be eligible for this trial, women must be 18 years or older and have a breast ultrasound that shows a solid mass that might be cancerous. Unfortunately, women under 18 or those who are not willing to consent to participate cannot join the study. Participants can expect to be part of an important effort to enhance breast cancer diagnosis in their community, and they will be helping to pave the way for better healthcare practices in Nigeria.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Age 18 and older female
• • Breast ultrasound demonstrating a solid mass that is suspicious for cancer, which would typically undergo either a blind biopsy or surgical excision at the Nigerian hospital where the patient is seeking diagnosis.
• Exclusion Criteria:
• • Participants unwilling to sign consent
• • Participants under the age of 18.